Back to Article

Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan

World Journal of Medical Microbiology | Vol 4, Issue 1

Figure 1

Comparisons of vaccine effectiveness among three vaccines of respiratory syncytial virus for adults. These data showed that vaccine effectiveness for the patients with three and more than three symptoms f lower respiratory tract illness (LRTI) in season 1 and season 2. Blue circles: Abrysvo (Pfizer), Black circles: Arexvy (GSK), Red circles: mRNA-1245 (Moderna), respectively.
Figure 1. Comparisons of vaccine effectiveness among three vaccines of respiratory syncytial virus for adults. These data showed that vaccine effectiveness for the patients with three and more than three symptoms f lower respiratory tract illness (LRTI) in season 1 and season 2. Blue circles: Abrysvo (Pfizer), Black circles: Arexvy (GSK), Red circles: mRNA-1245 (Moderna), respectively.
Download